Uni-Bio Science Group Limited provided earnings guidance for the year ended March 31, 2014. For the period, the group expects to record a significant increase in its net loss as compared to that for the financial year ended 31 March 2013. The significant increase in its net loss included (i) impairment losses in the fair value of the Group's intangible assets and goodwill, (ii) the increase in share-based payments expenses of the Group and (iii) loss on disposal of a subsidiary.